|
Drug Action: Pharmaceutic, Pharmacokinetic, and Pharmacodynamic Phases |
|
|
1 | (5) |
|
Nursing Process and Client Teaching |
|
|
6 | (3) |
|
Principles of Drug Administration |
|
|
9 | (5) |
|
Medications and Calculations |
|
|
14 | (41) |
|
The Drug Approval Process |
|
|
55 | (3) |
|
Transcultural and Genetic Considerations |
|
|
58 | (4) |
|
Drug Interactions and Over-the-Counter Drugs |
|
|
62 | (3) |
|
|
|
65 | (2) |
|
Herbal Therapy with Nursing Implications |
|
|
67 | (3) |
|
|
|
70 | (3) |
|
|
|
73 | (4) |
|
Medication Administration in Community Settings |
|
|
77 | (2) |
|
The Role of the Nurse in Drug Research |
|
|
79 | (2) |
|
Vitamin and Mineral Replacement |
|
|
81 | (3) |
|
Fluid and Electrolyte Replacement |
|
|
84 | (6) |
|
|
|
90 | (3) |
|
Adrenergics and Adrenergic Blockers |
|
|
93 | (4) |
|
Cholinergics and Anticholinergics |
|
|
97 | (4) |
|
Central Nervous System Stimulants |
|
|
101 | (4) |
|
Central Nervous System Depressants |
|
|
105 | (4) |
|
Drugs for Pain Management: Nonnarcotic and Narcotic Analgesics |
|
|
109 | (5) |
|
|
|
114 | (5) |
|
Drugs for Neurologic Disorders: Parkinsonism and Alzheimer's Disease |
|
|
119 | (3) |
|
Drugs for Neuromuscular Disorders: Myasthenia Gravis, Multiple Sclerosis, and Muscle Spasms |
|
|
122 | (3) |
|
Antipsychotics and Anxiolytics |
|
|
125 | (5) |
|
Antidepressants and Mood Stabilizer |
|
|
130 | (6) |
|
|
|
136 | (5) |
|
Antibacterials: Penicillins and Cephalosporins |
|
|
141 | (5) |
|
Antibacterials: Macrolides, Tetracyclines, Aminoglycosides, and Fluoroquinolones |
|
|
146 | (4) |
|
Antibacterials: Sulfonamides |
|
|
150 | (3) |
|
Antitubercular Drugs, Antifungal Drugs, Peptides, and Metronidazole |
|
|
153 | (5) |
|
Antiviral, Antimalarial, and Anthelmintic Drugs |
|
|
158 | (4) |
|
Drugs for Urinary Tract Disorders |
|
|
162 | (4) |
|
HIV and AIDS-Related Agents |
|
|
166 | (5) |
|
|
|
171 | (4) |
|
|
|
175 | (6) |
|
Biologic Response Modifiers |
|
|
181 | (4) |
|
Drugs for Common Upper Respiratory Disorders |
|
|
185 | (4) |
|
Drugs for Acute and Chronic Lower Respiratory Disorders |
|
|
189 | (4) |
|
Cardiac Glycosides, Antianginals, and Antidysrhythmics |
|
|
193 | (8) |
|
|
|
201 | (7) |
|
|
|
208 | (7) |
|
Anticoagulants, Antiplatelets, and Thrombolytics |
|
|
215 | (5) |
|
Antilipidemics and Peripheral Vasodilators |
|
|
220 | (4) |
|
Drugs for Gastrointestinal Tract Disorders |
|
|
224 | (6) |
|
|
|
230 | (6) |
|
Drugs for Disorders of the Eye and Ear |
|
|
236 | (4) |
|
Drugs for Dermatologic Disorders |
|
|
240 | (3) |
|
Endocrine Pharmacology: Pituitary, Thyroid, Parathyroids, and Adrenals |
|
|
243 | (5) |
|
|
|
248 | (9) |
|
Drugs Associated with the Female Reproductive Cycle I and II |
|
|
257 | (7) |
|
Drugs Associated with the Postpartum and the Newborn |
|
|
264 | (6) |
|
Drugs Related to Women's Health and Disorders |
|
|
270 | (8) |
|
Drugs Related to Reproductive Health: Male Reproductive Disorders |
|
|
278 | (3) |
|
Drugs Related to Reproductive Health: Infertility and Sexually Transmitted Diseases |
|
|
281 | (3) |
|
Adult and Pediatric Emergency Drugs |
|
|
284 | (6) |
| Answer Key |
|
290 | (63) |
| Appendix A Basic Math Review |
|
353 | (9) |
| Appendix B Prototype Drug Chart |
|
362 | |